ARB-type antihypertensives in the down-turning market
The Big 4 ARB-type antihypertensives – Twynsta(Boehringer Ingelheim), Amosartan(Hanmi Pharm), Exforge(Novartis) and Sevikar(Daiichi Sankyo) – have shown decreases altogether.
According to the UBIST data on the 28th, the highest prescribed ARB-type antihypertensive was Twynsta recording KRW 84.4 ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
